Leah Rosenbaum, Forbes Staff

Author's posts

BioNTech Stock Jumps Thanks To Imminent FDA Vaccine Approval

CEO Uğur Şahin’s net worth jumped $2.4 billion Wednesday, thanks to reports that his company’s Covid vaccine will be fully approved by Labor Day.

New Research Shines Light On How Covid-19 Can Damage The Brain

Research from the Alzheimer’s Association annual conference shows that Covid-19 can lead to cognitive issues — but many questions still remain.

How Good Are Covid-19 Vaccines At Protecting Against The Delta Variant?

Bottom line: All of the vaccines authorized for use in the U.S. are still very effective against the variant and greatly reduce the risk of severe disease, hospitalization or death.

Patients Can’t Be Charged Fees For A Covid-19 Vaccine — Including An ‘Administration Fee’

People are taking to social media to say that their insurance companies have charged illegal fees for “vaccine administration.”

Antibody Startup Adagio Raises $336 Million To Develop A Variant-Proof Treatment For Covid-19

The new company says it has a monoclonal antibody that is effective against all currently known variants of the coronavirus.

Covid-19 Weekly Roundup: What Happened With The Johnson & Johnson Vaccine?

The most important Covid-19 stories of the past week.

CDC Committee Declines To Vote On Johnson & Johnson Vaccine Safety, Pause Will Extend 7 To 10 Days

The CDC’s Advisory Committee on Immunization Practices decided to wait another seven to ten days before making any safety recommendations about the Johnson & Johnson vaccine.

Here’s What Scientists Know About Covid-19 Vaccine Blood Clots, And How The Risks Can Be Diminished

A link to rare blood clots have caused the rollout of the AstraZeneca and Johnson & Johnson Covid-19 vaccines to pause around the world. This is what scientists say about the risks and the next steps.

How Vaccine Companies Are Battling Covid-19 Variants

From newly designed vaccines to booster shots, pharma companies are fighting back against the more infectious variants that are taking over the world.

Two New Studies Show Link Between AstraZeneca-Oxford Vaccine And Rare Blood Clots

The studies say that the blood clots mimic complications that can occur with a common blood thinner.